drugset / Trial / NCT04094090
Safety and Effectiveness of the PXL-Platinum 330 System for Corneal Cross-Linking in Eyes With Corneal Ectasia
RandomizedSingle-groupSingle-blindTreatment
Summary
To evaluate the safety and effectiveness of the PXL Platinum 330 system for performing corneal cross-linking (CXL) for the treatment of ectatic disorders.
Timeline
- Start
- 2019-10-19
- Primary completion
- 2029-10-19
- Completion
- 2029-10-19
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Background | Riboflavin | Other / unclassified | — | — |